Skip to main content
. 2013 Aug 15;188(4):466–473. doi: 10.1164/rccm.201303-0588OC

TABLE 1.

DONOR, RECIPIENT, AND TRANSPLANT CHARACTERISTICS

Characteristic Donor Arrest (n = 479) No Donor Cardiac Arrest (Each Compared against Donor Arrest Group)
Full Sample (n = 9,076) P Value 1:1 Matched (n = 479) Standardized Difference*
Donor characteristics          
 Donor age 30 (21, 44) 32 (21, 46) 0.041 33 (22, 45) −0.088
 Donor diabetes 35 (7.3%) 561 (6.2%) 0.32 31 (6.5%) 0.032
 Donor smoking history 62 (13.1%) 1,105 (12.3%) 0.62 55 (11.6%) 0.046
 Donor cocaine use 67 (14.1%) 988 (11.1%) 0.039 55 (11.6%) 0.075
 Terminal creatinine, mg/dl 1.0 (0.8, 1.6) 1.0 (0.8, 1.3) <0.001 1.0 (0.8, 1.4) −0.011
 Donor BMI, kg/m2 25.1 (22.1, 28.7) 24.7 (22.1, 28.0) 0.05 24.7 (22.1, 27.7) 0.089
 Po2 on 100% inspired oxygen, mm Hg 405 (214, 488) 422 (256, 493) 0.001 421 (195, 492) −0.021
Recipient characteristics          
 Age 58 (47, 63) 58 (49, 64) 0.17 58 (47, 64) 0.005
 Female sex 200 (41.8%) 3,742 (41.2%) 0.82 200 (41.8%) 0.000
 White ethnicity 421 (87.9%) 7,659 (84.4%) 0.039 408 (85.2%) 0.079
 Diagnosis     0.029    
  Obstructive 154 (32.2%) 3,194 (35.2%)   143 (29.9%) 0.050
  Restrictive 229 (47.8%) 4,458 (49.1%)   231 (48.2%) −0.008
  CF or immunodeficiency 71 (14.8%) 1,135 (12.5%)   75 (15.7%) −0.025
  Pulmonary vascular 25 (5.2%) 289 (3.2%)   30 (6.3%) −0.047
 Diabetes 87 (18.2%) 1,600 (17.8%) 0.79 91 (19.1%) −0.023
 BMI (kg/m2) at transplant 24.9 (21.1, 28.4) 25.1 (21.3, 28.5) 0.49 25.1 (21.2, 28.7) −0.015
 Requiring ventilator at transplant 34 (7.1%) 510 (5.6%) 0.17 24 (5.0%) 0.088
 Pulmonary function          
  FEV1, % predicted 34 (20, 54) 34 (20, 52) 0.54 36 (21, 56) −0.046
  FVC, % predicted 46 (36, 59) 46 (36, 59) 0.88 46 (36, 61) −0.061
  FEV1/FVC 0.91 (0.47, 1.11) 0.86 (0.46, 1.10) 0.30 0.87 (0.49, 1.10) −0.009
 Lung allocation score 39.7 (34.7, 50.0) 38.9 (34.3, 47.9) 0.021 40.6 (34.7, 49.7) 0.010
 Days on waitlist 73 (23, 211) 74 (22, 233) 0.76 65 (21, 211) 0.001
Transplant characteristics          
 Bilateral transplant 330 (68.9%) 5,868 (64.7%) 0.06 329 (68.7%) 0.004
 Sex mismatch 142 (29.7%) 2,833 (31.2%) 0.47 164 (34.2%) −0.097
 Donor/recipient race mismatch 187 (39.0%) 3,811 (42.0%) 0.20 187 (39.0%) 0.000
 CMV mismatch 118/439 (26.9%) 2,141/8,449 (25.3%) 0.47 109/451 (24.2%) 0.062
 Ischemic time, h 5.2 (4.1, 6.3) 5.0 (3.9, 6.0) 0.030 5.2 (4.1, 6.3) 0.018

Definition of abbreviations: BMI = body mass index; CF = cystic fibrosis; CMV = cytomegalovirus; Po2 = arterial partial pressure of oxygen.

Shown are the median (interquartile range) for nonparametric continuous variables; n (%) for categorical variables. If data are missing for more than 5% of the study population, the denominator is give for categorical variables and “n” is given for continuous variables. The Wilcoxon signed-rank test was done for continuous variables, and the Pearson chi-squared test was done for categorical variables. Note that matched-pair comparisons of balance using standardized differences are explained in text.

*

Standardized difference is the difference in mean between the two groups divided by the square root of the pooled variance, with modification to reflect proportions for categorical variables (33).

Statistical significance.